HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.

Abstract
Neuromedin U (NMU) is an endogenous peptide, whose role in the regulation of feeding and energy homeostasis is well documented. Two NMU receptors have been identified: NMUR1, expressed primarily in the periphery, and NMUR2, expressed predominantly in the brain. We recently demonstrated that acute peripheral administration of NMU exerts potent but acute anorectic activity and can improve glucose homeostasis, with both actions mediated by NMUR1. Here, we describe the development of a metabolically stable analog of NMU, based on derivatization of the native peptide with high molecular weight poly(ethylene) glycol (PEG) ('PEGylation'). PEG size, site of attachment, and conjugation chemistry were optimized, to yield an analog which displays robust and long-lasting anorectic activity and significant glucose-lowering activity in vivo. Studies in NMU receptor-deficient mice showed that PEG-NMU displays an expanded pharmacological profile, with the ability to engage NMUR2 in addition to NMUR1. In light of these data, PEGylated derivatives of NMU represent promising candidates for the treatment of obesity and diabetes.
AuthorsPaolo Ingallinella, Andrea M Peier, Alessandro Pocai, Annalise Di Marco, Kunal Desai, Karolina Zytko, Ying Qian, Xiaobing Du, Antonella Cellucci, Edith Monteagudo, Ralph Laufer, Elisabetta Bianchi, Donald J Marsh, Antonello Pessi
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 20 Issue 15 Pg. 4751-9 (Aug 01 2012) ISSN: 1464-3391 [Electronic] England
PMID22771182 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Neuropeptides
  • PEG-NMU
  • Receptors, Neurotransmitter
  • neuromedin U receptor
  • neuromedin U
  • Polyethylene Glycols
Topics
  • Animals
  • Diabetes Mellitus, Experimental (drug therapy)
  • Dose-Response Relationship, Drug
  • Glucose Tolerance Test
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neuropeptides (administration & dosage, chemical synthesis, pharmacology)
  • Obesity (drug therapy)
  • Polyethylene Glycols (administration & dosage, chemical synthesis, chemistry, pharmacology)
  • Receptors, Neurotransmitter (agonists, deficiency)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: